{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:45:01Z","timestamp":1790833501355,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,7,28]],"date-time":"2004-07-28T00:00:00Z","timestamp":1090972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s00213-004-1941-4","type":"journal-article","created":{"date-parts":[[2004,7,27]],"date-time":"2004-07-27T17:24:33Z","timestamp":1090949073000},"page":"264-271","source":"Crossref","is-referenced-by-count":42,"title":["The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats"],"prefix":"10.1007","volume":"177","author":[{"given":"Marco","family":"Bortolato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Nicola","family":"Aru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Frau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Orr\ufffd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant Christopher","family":"Luckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Boi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Gessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,28]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0091-3057(94)00285-Q","volume":"50","author":"Acri","year":"1995","unstructured":"Acri JB, Brown KJ, Saah MI, Grunberg NE (1995) Strain and age differences in acoustic startle responses and effects of nicotine in rats. Pharmacol Biochem Behav 50:191?198","journal-title":"Pharmacol Biochem Behav"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0301-0082(98)00087-2","volume":"58","author":"Ameri","year":"1999","unstructured":"Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315?348","journal-title":"Prog Neurobiol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0024-3205(01)01366-2","volume":"70","author":"Arnold","year":"2001","unstructured":"Arnold JC, Hunt GE, McGregor IS (2001) Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats. Life Sci 70:97?108","journal-title":"Life Sci"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/bjp.178.2.101","volume":"178","author":"Ashton","year":"2001","unstructured":"Ashton CH (2001) Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 178:101?106","journal-title":"Br J Psychiatry"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000067064","volume":"35","author":"Bersani","year":"2002","unstructured":"Bersani G, Orlandi V, Gherardelli S, Pancheri P (2002) Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology. Psychopathology 35:289?295","journal-title":"Psychopathology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00213-003-1589-5","volume":"171","author":"Bortolato","year":"2004","unstructured":"Bortolato M, Frau R, Aru GN, Orru M, Gessa GL (2004) Baclofen reverses the reduction in prepulse inhibition of the acoustic startle response induced by dizocilpine, but not by apomorphine. Psychopharmacology 171:322?330","journal-title":"Psychopharmacology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archpsyc.1990.01810140081011","volume":"47","author":"Braff","year":"1990","unstructured":"Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47:181?188","journal-title":"Arch Gen Psychiatry"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","volume":"156","author":"Braff","year":"2001","unstructured":"Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234?258","journal-title":"Psychopharmacology"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.60.1.155","volume":"60","author":"Breivogel","year":"2001","unstructured":"Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155?163","journal-title":"Mol Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1615\/CritRevNeurobiol.v13.i3.20","volume":"13","author":"Chaperon","year":"1999","unstructured":"Chaperon F, Thiebot MH (1999) Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13:243?281","journal-title":"Crit Rev Neurobiol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0304-3940(91)90739-G","volume":"129","author":"Chen","year":"1991","unstructured":"Chen JP, Paredes W, Lowinson JH, Gardner EL (1991) Strain-specific facilitation of dopamine efflux by delta 9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study. Neurosci Lett 129:136?180","journal-title":"Neurosci Lett"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/210864a0","volume":"210","author":"Cladel","year":"1966","unstructured":"Cladel CE, Cho MH, McDonald RD (1966) Effect of amphetamine and catecholamines on startle response and general motor activity of albino rats. Nature 210:864?865","journal-title":"Nature"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1300\/J251v09n01_08","volume":"9","author":"Compton","year":"1990","unstructured":"Compton DR, Dewey WL, Martin BR (1990) Cannabis dependence and tolerance production. Adv Alcohol Subst Abuse 9:129?147","journal-title":"Adv Alcohol Subst Abuse"},{"key":"CR14","first-page":"1150","volume":"285","author":"Cook","year":"1998","unstructured":"Cook SA, Lowe JA, Martin BR (1998) CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 285:1150?1156","journal-title":"J Pharmacol Exp Ther"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00426027","volume":"62","author":"Davis","year":"1979","unstructured":"Davis M (1979) Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm. Psychopharmacology 62:1?7","journal-title":"Psychopharmacology"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.02-06-00791.1982","volume":"2","author":"Davis","year":"1982","unstructured":"Davis M, Gendelman DS, Tischler MD, Gendelman PM (1982) A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci 2:791?805","journal-title":"J Neurosci"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11920-002-0026-5","volume":"4","author":"Degenhardt","year":"2002","unstructured":"Degenhardt L, Hall W (2002) Cannabis and psychosis. Curr Psychiatry Rep 4:191?196","journal-title":"Curr Psychiatry Rep"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0376-8716(03)00064-4","volume":"71","author":"Degenhardt","year":"2003","unstructured":"Degenhardt L, Hall W, Lynskey M (2003) Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 71:37?48","journal-title":"Drug Alcohol Depend"},{"key":"CR19","first-page":"605","volume":"34","author":"Devane","year":"1988","unstructured":"Devane WA, Dysarz FA III, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605?613","journal-title":"Mol Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946?1949","journal-title":"Science"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","volume":"372","author":"Di","year":"1994","unstructured":"Di Marzo V, Fontana A, Cadas H, chinelli S, Cimino G, Schwartz JC, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide. Nature 372:686?691","journal-title":"Nature"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/ajp.148.2.224","volume":"148","author":"Dixon","year":"1991","unstructured":"Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ (1991) Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 148:224?230","journal-title":"Am J Psychiatry"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0959-4388(97)80092-X","volume":"7","author":"Egan","year":"1997","unstructured":"Egan MF, Weinberger DR (1997) Neurobiology of schizophrenia. Curr Opin Neurobiol 7:701?707","journal-title":"Curr Opin Neurobiol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002130050892","volume":"142","author":"Ehrenreich","year":"1999","unstructured":"Ehrenreich H, Rinn T, Kunert HJ, Moeller MR, Poser W, Schilling L, Gigerenzer G, Hoehe MR (1999) Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology 142:295?301","journal-title":"Psychopharmacology"},{"key":"CR25","first-page":"887","volume":"166","author":"Fried","year":"2002","unstructured":"Fried P, Watkinson B, James D, Gray R (2002) Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults. CMAJ 166:887?891","journal-title":"CMAJ"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1006\/nbdi.1998.0219","volume":"5","author":"Gardner","year":"1998","unstructured":"Gardner EL, Vorel SR (1998) Cannabinoid transmission and reward-related events. Neurobiol Dis 5:502?533","journal-title":"Neurobiol Dis"},{"key":"CR27","doi-asserted-by":"crossref","unstructured":"Geyer MA, Swerdlow NR (1998) Measurement of startle response, prepulse inhibition, and habituation. In: Crawley JN, Skolnick P (eds) Current protocols in neuroscience. Suppl 3, Chapter 8. Wiley, New York, pp 1?15","DOI":"10.1002\/0471142301.ns0807s03"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"Geyer","year":"2001","unstructured":"Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117?154","journal-title":"Psychopharmacology"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/7268","volume":"2","author":"Giuffrida","year":"1999","unstructured":"Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358?363","journal-title":"Nat Neurosci"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01067931","volume":"24","author":"Glowa","year":"1994","unstructured":"Glowa JR, Hansen CT (1994) Differences in response to an acoustic startle stimulus among forty-six rat strains. Behav Genet 24:79?84","journal-title":"Behav Genet"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1469-8986.1975.tb01284.x","volume":"12","author":"Graham","year":"1975","unstructured":"Graham FK (1975) The more or less startling effects of weak prestimulation. Psychophysiology 12:238?248","journal-title":"Psychophysiology"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"Grotenhermen","year":"2003","unstructured":"Grotenhermen F (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42:327?360","journal-title":"Clin Pharmacokinet"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1177\/009127002401382740","volume":"42","author":"Harrison","year":"2002","unstructured":"Harrison GP Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D (2002) Cognitive measures in long-term cannabis users. J Clin Pharmacol 42[Suppl 11]:41S?47S","journal-title":"J Clin Pharmacol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.1992.tb25953.x","volume":"654","author":"Herkenham","year":"1992","unstructured":"Herkenham M (1992) Cannabinoid receptor localization in brain: relationship to motor and reward systems. Ann N Y Acad Sci 654:19?32","journal-title":"Ann N Y Acad Sci"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87:1932?1936","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(91)90970-7","volume":"547","author":"Herkenham","year":"1991","unstructured":"Herkenham M, Lynn AB, de Costa BR, Richfield EK (1991) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res 547:267?274","journal-title":"Brain Res"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.pa.35.040195.003135","volume":"35","author":"Howlett","year":"1995","unstructured":"Howlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607?634","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"CR38","doi-asserted-by":"crossref","unstructured":"Jones RT, Benowitz NL, Herning RI (1981) Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 21[Suppl 8?9 ]:143S?152S","DOI":"10.1002\/j.1552-4604.1981.tb02589.x"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1176\/ajp.128.2.213","volume":"128","author":"Keeler","year":"1971","unstructured":"Keeler MH, Ewing JA, Rouse BA (1971) Hallucinogenic effects of marijuana as currently used. Am J Psychiatry 128:213?216","journal-title":"Am J Psychiatry"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0301-0082(98)00098-7","volume":"59","author":"Koch","year":"1999","unstructured":"Koch M (1999) The neurobiology of startle. Prog Neurobiol 59:107?128","journal-title":"Prog Neurobiol"},{"key":"CR41","first-page":"567","volume":"44","author":"Kovasznay","year":"1993","unstructured":"Kovasznay B, Bromet E, Schwartz JE, Ram R, Lavelle J, Brandon L (1993) Substance abuse and onset of psychotic illness. Hosp Community Psychiatry 44:567?571","journal-title":"Hosp Community Psychiatry"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0920-9964(98)00162-5","volume":"35","author":"Krystal","year":"1999","unstructured":"Krystal JH, D?Souza DC, Madonick S, Petrakis IL (1999) Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients. Schizophr Res 35[Suppl]:S35?S49","journal-title":"Schizophr Res"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1002\/j.1552-4604.2002.tb05999.x","volume":"42","author":"Lichtman","year":"2002","unstructured":"Lichtman AH, Martin BR (2002) Marijuana withdrawal syndrome in the animal model. J Clin Pharmacol 42[Suppl 11]:20S?27S","journal-title":"J Clin Pharmacol"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1360-0443.1997.tb03372.x","volume":"92","author":"Lyons","year":"1997","unstructured":"Lyons MJ, Toomey R, Meyer JM, Green AI, Eisen SA, Goldberg J, True WR, Tsuang MT (1997) How do genes influence marijuana use? The role of subjective effects. Addiction 92:409?417","journal-title":"Addiction"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3940(92)90832-R","volume":"148","author":"Mailleux","year":"1992","unstructured":"Mailleux P, Vanderhaeghen JJ (1992) Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons. Neurosci Lett 148:173?176","journal-title":"Neurosci Lett"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1523\/JNEUROSCI.22-09-03326.2002","volume":"22","author":"Maldonado","year":"2002","unstructured":"Maldonado R, Rodriguez de Fonseca F (2002) Cannabinoid addiction: behavioral models and neural correlates. J Neurosci 22:3326?3331","journal-title":"J Neurosci"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF02247436","volume":"124","author":"Mansbach","year":"1996","unstructured":"Mansbach RS, Rovetti CC, Winston EN, Lowe JA III (1996) Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology 124:315?322","journal-title":"Psychopharmacology"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","volume":"40","author":"Martin","year":"1991","unstructured":"Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, Ward SJ (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 40:471?478","journal-title":"Pharmacol Biochem Behav"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00213-002-1240-x","volume":"165","author":"Martin","year":"2003","unstructured":"Martin RS, Secchi RL, Sung E, Lemaire M, Bonhaus DW, Hedley LR, Lowe DA (2003) Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat. Psychopharmacology 165:128?135","journal-title":"Psychopharmacology"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.1976.tb49899.x","volume":"282","author":"Mendelson","year":"1976","unstructured":"Mendelson JH, Babor TF, Kuehnle JC, Rossi AM, Bernstein JG, Mello NK, Greenberg I (1976) Behavioral and biologic aspects of marijuana use. Ann N Y Acad Sci 282:186?210","journal-title":"Ann N Y Acad Sci"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61?65","journal-title":"Nature"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0091-3057(02)00910-3","volume":"73","author":"Muschamp","year":"2002","unstructured":"Muschamp JW, Siviy SM (2002) Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55,212-2 in Lewis rats. Pharmacol Biochem Behav 73:835?842","journal-title":"Pharmacol Biochem Behav"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-4328(93)90059-Y","volume":"57","author":"Navarro","year":"1993","unstructured":"Navarro M, Fernandez-Ruiz JJ, de Miguel R, Hernandez ML, Cebeira M, Ramos JA (1993) An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. Behav Brain Res 57:37?46","journal-title":"Behav Brain Res"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0367-326X(00)00171-4","volume":"71","author":"Nocerino","year":"2000","unstructured":"Nocerino E, Amato M, Izzo AA (2000) Cannabis and cannabinoid receptors. Fitoterapia 71[Suppl 1]:S6?S12","journal-title":"Fitoterapia"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0009-3084(02)00143-3","volume":"121","author":"Palmer","year":"2002","unstructured":"Palmer SL, Thakur GA, Makriyannis A (2002) Cannabinergic ligands. Chem Phys Lipids 121:3?19","journal-title":"Chem Phys Lipids"},{"key":"CR56","first-page":"129","volume":"74","author":"Pertwee","year":"1997","unstructured":"Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129?180","journal-title":"Pharmacol Ther"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","volume":"6","author":"Pertwee","year":"1999","unstructured":"Pertwee RG. (1999) Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6:635?664","journal-title":"Curr Med Chem"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0163-7258(02)00258-9","volume":"95","author":"Randall","year":"2002","unstructured":"Randall MD, Harris D, Kendall DA, Ralevic V (2002) Cardiovascular effects of cannabinoids. Pharmacol Ther 95:191?202","journal-title":"Pharmacol Ther"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","volume":"264","author":"Regier","year":"1990","unstructured":"Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264:2511?2518","journal-title":"JAMA"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF02244115","volume":"102","author":"Rigdon","year":"1990","unstructured":"Rigdon GC (1990) Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rat strain. Psychopharmacology 102:419?421","journal-title":"Psychopharmacology"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0031-9384(85)90164-7","volume":"35","author":"Rinaldi","year":"1985","unstructured":"Rinaldi PC, Thompson RF (1985) Age, sex and strain comparison of habituation of the startle response in the rat. Physiol Behav 35:9?13","journal-title":"Physiol Behav"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00008877-200202000-00003","volume":"13","author":"Schneider","year":"2002","unstructured":"Schneider M, Koch M (2002) The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats. Behav Pharmacol 13:29?37","journal-title":"Behav Pharmacol"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.npp.1300225","volume":"28","author":"Schneider","year":"2003","unstructured":"Schneider M, Koch M (2003) Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 28:1760?1769","journal-title":"Neuropsychopharmacology"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1046\/j.1471-4159.2001.00308.x","volume":"77","author":"Selley","year":"2001","unstructured":"Selley DE, Rorrer WK, Breivogel CS, Zimmer AM, Zimmer A, Martin BR, Sim-Selley LJ. (2001) Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation. J Neurochem 77:1048?1057","journal-title":"J Neurochem"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00008877-200202000-00002","volume":"13","author":"Stanley-Cary","year":"2002","unstructured":"Stanley-Cary CC, Harris C, Martin-Iverson MT (2002) Differing effects of the cannabinoid agonist, CP 55,940, in an alcohol or Tween 80 solvent, on prepulse inhibition of the acoustic startle reflex in the rat. Behav Pharmacol 13:15?28","journal-title":"Behav Pharmacol"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1101\/lm.7.3.132","volume":"7","author":"Sullivan","year":"2000","unstructured":"Sullivan JM (2000) Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn Mem 7:132?139","journal-title":"Learn Mem"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1994.03950020063007","volume":"51","author":"Swerdlow","year":"1994","unstructured":"Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139?154","journal-title":"Arch Gen Psychiatry"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0893-133X(97)00110-3","volume":"18","author":"Swerdlow","year":"1998","unstructured":"Swerdlow NR, Varty GB, Geyer MA (1998) Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat? Neuropsychopharmacology 18:50?56","journal-title":"Neuropsychopharmacology"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00008877-200006000-00002","volume":"11","author":"Swerdlow","year":"2000","unstructured":"Swerdlow NR, Braff DL, Geyer MA (2000) Animal models of sensorimotor gating: what we know, what we think we know, and what we hope we know soon. Behav Pharmacol 11:185?204","journal-title":"Behav Pharmacol"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3758\/BF03200069","volume":"14","author":"Wecker","year":"1986","unstructured":"Wecker JR, Ison JR (1986) Effects of motor activity on the elicitation and modification of the startle reflex in rats. Anim Learn Behav 14:287?292","journal-title":"Anim Learn Behav"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1360-0443.1996.tb02251.x","volume":"91","author":"Wiesbeck","year":"1996","unstructured":"Wiesbeck GA, Schuckit MA, Kalmijn JA, Tipp JE, Bucholz KK, Smith TL (1996) An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction 91:1469?1478","journal-title":"Addiction"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-1941-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-004-1941-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-1941-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T02:54:00Z","timestamp":1682736840000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-004-1941-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,28]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["1941"],"URL":"https:\/\/doi.org\/10.1007\/s00213-004-1941-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,28]]}}}